Fetal Anatomy by Three-Dimensional Ultrasound
2 other identifiers
observational
3,650
1 country
2
Brief Summary
A major goal of perinatal care is to accurately diagnose fetal anomalies prior to birth. This capability allows clinicians to make prudent decisions regarding antepartum care, delivery site, and postnatal therapy. Three-dimensional ultrasound is a recent technology that provides a new way to evaluate the fetus. This technique allows one to scan through a digital ultrasound volume dataset, visualize organs from different perspectives, measure volumes, and render anatomical features through computer processing. However, the accurate characterization of fetal anomalies by this technique must be interpreted in relation to normal fetal anatomy at different stages of pregnancy. We are continuing to develop an image reference library of fetal anatomy by identifying key diagnostic features by three-dimensional ultrasound. A cross-sectional observational study of up to 1,400 fetuses will catalog a broad spectrum of congenital malformations at various gestational ages. The protocol will include up to 400 examples of normal fetal anatomy by three-dimensional ultrasonography. All cases will be placed into a digital image database. For each anomaly category, volume reconstructions will be compared to normal anatomy at specific gestational ages. Key diagnostic findings will be documented and correlated with postnatal outcome. We anticipate that our results will permit improved diagnostic interpretation of congenital defects throughout pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 1997
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 26, 1997
CompletedFirst Submitted
Initial submission to the registry
June 19, 2006
CompletedFirst Posted
Study publicly available on registry
June 21, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 18, 2016
CompletedFebruary 24, 2023
February 1, 2023
19 years
June 19, 2006
February 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fetal Anatomy
Data analysis is ongoing
Ongoing
Study Arms (1)
Pregnant women
Pregnant women aged 18 years and older
Eligibility Criteria
Pregnant women attending Detroit Medical Center prenatal clinics in Detroit.
You may qualify if:
- All pregnant subjects will be recruited under informed consent at either Hutzel or William Beaumont Hospitals.
- The study population for both arms of this protocol will involve pregnant women greater than or equal to 15 years.
- CROSS-SECTIONAL ARM OF PROTOCOL - NORMAL FETUS SUBJECTS:
- DUS STUDIES:
- No fetal anomalies suspected by 2DUS.
- Excellent visualization of normal fetal anatomy by 2DUS.
- Accurate dating criteria by 1st trimester scan and/or menstrual history.
- FETAL MRI STUDIES:
- Gestational age between 18-42 menstrual weeks.
- No known fetal abnormalities.
- CROSS-SECTIONAL ARM OF PROTOCOL - ABNORMAL FETUSES:
- DUS STUDIES:
- Congenital anomaly suspected by 2DUS.
- Accurate dating criteria by 1st trimester scan and/or menstrual history.
- FETAL MRI STUDIES:
- +4 more criteria
You may not qualify if:
- CROSS-SECTIONAL ARM OF PROTOCOL - NORMAL FETUS SUBJECTS:
- DUS STUDIES:
- Poor visualization of the fetus due to technical factors (e.g. obesity, surgical scar).
- History of noncompliance with prenatal visits with the current or prior pregnancy.
- FETAL MRI STUDIES:
- Inability of the patient to fit in bore of MRI system.
- Metallic implants that would increase risk to patient.
- Previous occupational exposure to metal shop.
- History of claustrophobia.
- CROSS-SECTIONAL ARM OF PROTOCOL - ABNORMAL FETUSES:
- DUS STUDIES:
- Poor fetal visualization from technical factors (e.g. obesity or decreased amniotic fluid).
- FETAL MRI STUDIES:
- Inability of the patient to fit in bore of MRI system.
- Metallic implants that would increase risk to patient.
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hutzel Women's Hospital
Detroit, Michigan, 48201, United States
William Beaumont Hospital
Royal Oak, Michigan, United States
Related Publications (3)
Kuo HC, Chang FM, Wu CH, Yao BL, Liu CH. The primary application of three-dimensional ultrasonography in obstetrics. Am J Obstet Gynecol. 1992 Mar;166(3):880-6. doi: 10.1016/0002-9378(92)91355-e.
PMID: 1550157BACKGROUNDLee A, Deutinger J, Bernaschek G. "Voluvision": three-dimensional ultrasonography of fetal malformations. Am J Obstet Gynecol. 1994 May;170(5 Pt 1):1312-4. doi: 10.1016/s0002-9378(94)70148-2.
PMID: 8178859BACKGROUNDSteiner H, Staudach A, Spitzer D, Schaffer H. Three-dimensional ultrasound in obstetrics and gynaecology: technique, possibilities and limitations. Hum Reprod. 1994 Sep;9(9):1773-8. doi: 10.1093/oxfordjournals.humrep.a138793.
PMID: 7836537BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roberto Romero, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 19, 2006
First Posted
June 21, 2006
Study Start
November 26, 1997
Primary Completion
November 18, 2016
Study Completion
November 18, 2016
Last Updated
February 24, 2023
Record last verified: 2023-02